ニューヨークにおけるループスの臨床試験
ニューヨーク内の拠点で、ループスに関する26件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50010, Brooklyn
- Sl0044 50264, Manhasset
- Sl0044 50077, New York
- 他1件
被験者募集中第3相
16歳以上 · 全性別 · 2026/10/02更新 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/10/01更新 · NCT05268289An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, New Hyde Park
- Research Site, New York
- Research Site, The Bronx
- 他1件
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/30更新 · NCT05835310Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
被験者募集中第2相
16歳〜70歳 · 全性別 · 2026/09/17更新 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
- Feinstein Institutes for Medical Research, Manhasset
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06987565HEALTH Home Urinalysis Testing
- NYU Langone Health, New York
被験者募集中
18歳以上 · 全性別 · 2026/09/16更新 · NCT07823478A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/09/10更新 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- New York University School Of Medicine, New York
被験者募集中第4相
18歳〜75歳 · 全性別 · 2026/09/09更新 · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Kings County Hospital Center - Brooklyn, Brooklyn
被験者募集中観察研究
16歳以上 · 全性別 · 2026/09/03更新 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2026/08/26更新 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
被験者募集中第2相
12歳〜65歳 · 全性別 · 2026/08/24更新 · NCT07053800A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Northwell Health, Great Neck
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/21更新 · NCT06570798Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- 他2件
被験者募集中第3相
55歳以上 · 全性別 · 2026/08/20更新 · NCT05799378A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Fairport
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/07/27更新 · NCT07260877Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07138898Trial of Belimumab in Early Lupus
- Feinstein Institute, Manhasset
被験者募集中第4相
18歳以上 · 全性別 · 2026/06/12更新 · NCT03543839A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/06/05更新 · NCT06613360A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US08-0, Syracuse
被験者募集中第1/2相健康なボランティア歓迎
18歳〜70歳 · 全性別 · 2026/06/02更新 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
被験者募集中第1相
12歳〜70歳 · 全性別 · 2026/05/22更新 · NCT06308978Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
被験者募集中観察研究健康なボランティア歓迎
18歳〜45歳 · 女性 · 2026/04/28更新 · NCT00198068Alnuctamab for Refractory SLE (LATTE Study)
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第1相
18歳〜60歳 · 全性別 · 2026/04/21更新 · NCT07219563Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- 他1件
被験者募集中観察研究
18歳〜110歳 · 全性別 · 2026/04/15更新 · NCT05934149Safety of the Herpes Zoster Subunit Vaccine in Lupus
- NYU Langone Health, New York
被験者募集中第4相
18歳〜90歳 · 全性別 · 2025/12/26更新 · NCT05559671Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
被験者募集中早期第1相
18歳以上 · 全性別 · 2025/11/20更新 · NCT07107659ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。